F10 and ischemic stroke: Finally, the patient’s transition to oral anticoagulation with a Factor Xa inhibitor (Rivaroxaban) and referral for comprehensive hematological assessment ensured adequate secondary prevention and allowed for investigation of an underlying prothrombotic state, given the patient’s prior ischemic stroke and chronic venous insufficiency.